Remicade

Pfizer set to start shipping Remicade biosimilar next month
Yahoo/Reuters
Tue, 10/18/16 - 12:03 am
Pfizer
Remicade
biosimilars
Inflectra
JNJ
rheumatoid arthritis
Pfizer Takes Aim at Johnson & Johnson
Motley Fool
Mon, 09/12/16 - 09:23 am
Pfizer
JNJ
Remicade
biosimilar
Inflectra
With Biogen launch, the U.K. has two anti-TNF biosims. In the U.S.? Not soon, analyst says
Fierce Pharma
Thu, 09/8/16 - 06:37 pm
Biogen
UK
anti-TNF
biosimilars
Flixabi
Remicade
Enbrel
Benepali
Deutsche Takes A Look At Johnson & Johnson's Patent Woes
Yahoo/Benzinga
Fri, 08/19/16 - 11:34 am
JNJ
patents
Remicade
Pfizer
biosimilars
rheumatoid arthritis
J&J Remicade Patent Found Invalid in U.S. Victory for Pfizer
Bloomberg
Thu, 08/18/16 - 04:13 pm
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Celltrion
Hospira
Will the approval of Inflectra be a biosimilar adoption tipping point?
BioPharma Dive
Fri, 06/10/16 - 10:18 am
Inflectra
biosimilars
Celltrion
Remicade
JNJ
rheumatoid arthritis
Samsung Bioepis notches European Commission nod for Remicade biosim
Fierce Pharma
Mon, 05/30/16 - 11:05 am
Samsung Bioepis
Europe
Flixabi
Remicade
biosimilars
JNJ
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
Yahoo/Reuters
Mon, 05/23/16 - 09:41 pm
Samsung Bioepis
Remicade
biosimilars
FDA
rheumatoid arthritis
JNJ
Why Is Remicade Driving Down Merck’s Performance?
Yahoo/Market Realist
Mon, 05/16/16 - 09:30 pm
Remicade
Merck
With competition lurking, Eli Lilly's baricitinib must show unparalled efficacy
Medical Marketing and Media
Wed, 05/11/16 - 10:52 am
Eli Lilly
baricitinib
JAK inhibitors
Pfizer
Xeljanz
Enbrel
AbbVie
Humira
JNJ
Remicade
FDA Licenses a Second Biosimilar – The Parameters of Approval Come Into Better Focus
FDA Law Blog
Thu, 04/7/16 - 09:49 am
FDA
biosimilars
JNJ
Remicade
Inflectra
Pfizer
Celltrion
FDA approves 1st cheaper version of J&J's top drug Remicade
Yahoo/AP
Tue, 04/5/16 - 10:16 pm
FDA
Remicade
JNJ
Inflectra
biosimilars
Celltrion
Pfizer
Switching study gives Celltrion biosim more ammo in fight for Remicade share
Fierce Pharma Marketing
Tue, 03/22/16 - 09:54 am
Celltrion
biosimilars
Merck
Remicade
Remsima
Why Is Remicade Driving Down Merck’s Immunology Franchise?
Yahoo/Market Realist
Sun, 03/6/16 - 02:56 pm
Remicade
Merck
The Generic Drug Battle
Yahoo/Benzinga
Wed, 02/10/16 - 10:29 am
generics
biosimilars
JNJ
Pfizer
Remicade
FDA panel backs Pfizer and Celltrion's Remicade biosimilar over J&J's objections
Fierce Biotech
Tue, 02/9/16 - 05:35 pm
FDA
advisory panels
Pfizer
Celltrion
Remicade
JNJ
biosimilars
Is the Anti-TNF Lead of AbbVie, Amgen, JNJ Nearing an End?
Bidness, ETC
Mon, 02/8/16 - 11:01 am
AbbVie
Amgen
JNJ
anti-TNF
Remicade
Biogen Inc. Takes Aim at Johnson & Johnson
Motley Fool
Sun, 02/7/16 - 10:45 am
Biogen
JNJ
Samsung Bioepis
Remicade
FDA reviewers support Celltrion's biosimilar Remicade
Yahoo/Reuters
Fri, 02/5/16 - 09:21 am
FDA
Celltrion
biosimilars
Remicade
arthritis
Remsima
JNJ
Pfizer
Biosimilars Are Coming After Big Pharma's Bottom Line
Fortune
Tue, 01/12/16 - 02:37 pm
Big Pharma
biosimilars
Roche
AbbVie
MabThera
Herceptin
Avastin
Humira
Janssen
Remicade

Pages